文献速递颈动脉与弓上血管

颈动脉支架内狭窄的进展率及临床结局

Rates of progression of carotid in-stent stenosis and clinical outcomes.
PubMed 文献 · J Vasc Surg · 2022-07-11

回顾性分析450例经股动脉颈动脉支架置入术患者的前瞻性数据,平均随访70.3个月。结果显示支架内狭窄进展率中等,卒中事件发生率低(2.7%出现同侧短暂性脑缺血发作或卒中),作者认为支架置入术后双功能超声监测应选择性使用,其获益与效用或许需要重新评估。

要点

  • 平均随访70.3个月,446例中121例(27%)进展至≥50%支架内狭窄,39例(8.7%)进展至≥80%。
  • 446例中12例(2.7%)在平均70个月随访中发生同侧短暂性脑缺血发作或卒中。
  • 作者认为颈动脉支架置入术后双功能超声监测应选择性使用,其获益与效用或许需要重新评估。

核心结论

  • 颈动脉支架内狭窄的进展率中等,卒中事件发生率低;因此颈动脉支架置入术后双功能超声监测应选择性使用,其获益与效用或许需要重新评估。

研究设计与样本

  • 回顾性分析前瞻性收集的450例接受经股动脉颈动脉支架置入术患者的数据,平均随访70个月(范围1-222个月)。
  • 支架内狭窄进展定义为狭窄进展至更高疾病严重程度,即从<50%进展至≥50%,以及从≥50%进展至≥80%。
  • 采用Kaplan-Meier分析估计从<50%至≥50%、从≥50%至≥80%的进展率,≥50%和≥80%支架内狭窄的总体发生率,以及1、3、5、10年生存率。

主要发现

  • 平均随访70.3个月(范围1-222个月),446例中121例(27%)进展至≥50%支架内狭窄,39例(8.7%)进展至≥80%支架内狭窄。
  • 406例首次双功能超声正常或支架内狭窄<50%的患者中,82例在平均51.7个月(范围1-213个月)进展至≥50%支架内狭窄;121例≥50%狭窄患者中,14例(11.6%)在平均33.6个月(范围6-89个月)进展至≥80%。
  • 82例从<50%进展至≥50%的患者中,10例(12%)发生神经系统事件(8例短暂性脑缺血发作,2例卒中);14例从≥50%进展至≥80%的患者中,2例(14.3%)发生短暂性脑缺血发作,其余无症状;39例≥80%支架内狭窄患者中,9例(23%)发生神经系统事件(8例短暂性脑缺血发作,1例对侧卒中)。
  • 121例晚期≥50%再狭窄患者中,13例(10.7%)发生神经系统事件(10例同侧短暂性脑缺血发作,2例同侧卒中,1例对侧卒中);446例中12例(2.7%)在平均70个月随访中发生同侧短暂性脑缺血发作或卒中。
  • 从<50%至≥50%支架内狭窄进展的无事件率在1、3、5、10年分别为93%、85%、78%、66%;从≥50%至≥80%进展的无事件率在1、3、5年分别为89%、81%、77%;≥50%支架内狭窄的总体无事件率在1、3、5、10年分别为86%、77%、71%、59%,≥80%支架内狭窄的总体无事件率分别为96%、93%、91%、84%;卒中生存率在1、3、5、10年分别为95%、80%、63%、31%。

临床怎么用

  • 作者认为,颈动脉支架置入术后双功能超声监测应选择性使用,其获益与效用或许需要重新评估。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We previously reported the incidence of ≥50% and ≥80% carotid in-stent stenosis. In the present study, we analyzed the rate of progression of in-stent stenosis and clinical outcomes with longer follow-up. METHODS: We performed a retrospective analysis of prospectively collected data for 450 patients who had undergone transfemoral carotid artery stenting with longer follow-up (mean, 70 months). The progression of in-stent stenosis was defined as stenosis advancing to a higher severity of disease (ie, from <50% to ≥50% and from ≥50% to ≥80%). Kaplan-Meier analysis was used to estimate the rate of progression from <50% to ≥50% and ≥50% to ≥80%, the overall rates of ≥50% and ≥80% in-stent stenosis, and survival at 1, 3, 5, and 10 years. RESULTS: At a mean follow-up of 70.3 months (range, 1-222 months), 121 of 446 patients (27%) had had progression to ≥50% and 39 (8.7%) to ≥80% in-stent stenosis. Of the 406 patients whose first duplex ultrasound findings were normal or showed in-stent stenosis of <50%, 82 had had progression from normal or <50% to ≥50% in-stent stenosis at a mean of 51.7 months (range, 1-213 months). Of the 121 patients with ≥50% stenosis, 14 (11.6%) had experienced progression to ≥80% at a mean of 33.6 months (range, 6-89 months). Of the 82 patients with progression from <50 to ≥50%, 10 (12%) had experienced a neurologic event (eight transient ischemic attacks [TIAs] and two strokes). Of the 14 with progression from ≥50% to ≥80%, 2 (14.3%) had experienced a TIA, and the remaining patients were asymptomatic. Of the 39 patients with ≥80% in-stent stenosis, 9 (23%) had experienced a neurologic event (eight TIAs and one contralateral stroke). Overall, 13 of the 121 patients with late ≥50% restenosis (10.7%) had experienced a neurologic event (10 ipsilateral TIA, 2 ipsilateral stroke, and 1 contralateral stroke. Thus, 12 of 446 patients (2.7%) had experienced an ipsilateral TIA or stroke at a mean follow-up of 70 months. The rates of freedom from <50% to ≥50% in-stent stenosis progression were 93%, 85%, 78%, and 66% at 1, 3, 5, and 10 years. The rates of freedom from progression from ≥50% to ≥80% in-stent stenosis were 89%, 81%, and 77% at 1, 3, and 5 years, respectively. The overall rates of freedom from ≥50% in-stent stenosis and ≥80% in-stent stenosis were 86%, 77%, 71%, and 59% and 96%, 93%, 91%, and 84% at 1, 3, 5, and 10 years, respectively. Finally, the stroke survival rates were 95%, 80%, 63%, and 31% at 1, 3, 5, and 10 years, respectively. CONCLUSIONS: The rate of progression of carotid in-stent stenosis was modest, with a low incidence of stroke events. Therefore, the use of duplex ultrasound surveillance after carotid artery stenting should be selective and its benefits and utility perhaps reevaluated.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. AbuRahma AF, Santini AG, AbuRahma ZT, et al. Rates of progression of carotid in-stent stenosis and clinical outcomes. J Vasc Surg. 2022. PMID: 35835321. doi:10.1016/j.jvs.2022.07.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。